Publicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (33)

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  3. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases

  4. Erratum to «Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper» [Arch Bronconeumol. 2024;60(3):161–170] (Archivos de Bronconeumología (2024) 60(3) (161–170), (S0300289624000061), (10.1016/j.arbres.2024.01.004))

    Archivos de Bronconeumologia

  5. Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia

    Genes and Diseases, Vol. 11, Núm. 3

  6. Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain

    Emerging Microbes and Infections

  7. New Vaccines for Chronic Respiratory Patients

    Archivos de Bronconeumologia

  8. Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 161-170

  9. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

2023

  1. Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract

    Journal of Infection, Vol. 87, Núm. 6, pp. 538-550

  2. COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain

    Pediatric Allergy and Immunology, Vol. 34, Núm. 10

  3. Chatting with ChatGPT to learn about safety of COVID-19 vaccines–A perspective

    Human Vaccines and Immunotherapeutics

  4. Erratum: Correction to: Febrile illness in high-risk children: a prospective, international observational study (European journal of pediatrics (2023) 182 2 (543-554))

    European journal of pediatrics

  5. Febrile illness in high-risk children: a prospective, international observational study

    European Journal of Pediatrics, Vol. 182, Núm. 2, pp. 543-554

  6. Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons

    Archivos de Bronconeumologia, Vol. 59, Núm. 8, pp. 531-533

  7. Music compensates for altered gene expression in age-related cognitive disorders

    Scientific Reports, Vol. 13, Núm. 1

  8. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

    The Lancet Infectious Diseases, Vol. 23, Núm. 7, pp. 856-866

  9. Relationship between molecular pathogen detection and clinical disease in febrile children across Europe: a multicentre, prospective observational study

    The Lancet Regional Health - Europe, Vol. 32

  10. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 4, pp. 341-353

  11. Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group

    Antibiotics, Vol. 12, Núm. 1